| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |